Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation

Stem Cells

Volumn 33, Issue 4, 2015, Pages 1187-1199

  Pisano, Federica ^a,b   Altomare, Claudia ^b   Cervio, Elisabetta ^a,b   Barile, Lucio ^b   Rocchetti, Marcella ^b   Ciuffreda, Maria Chiara ^a,b   Malpasso, Giuseppe ^a,b,c   Copes, Francesco ^a   Mura, Manuela ^a,b,c   Danieli, Patrizia ^a,b   Viarengo, Gianluca ^d   Zaza, Antonio ^b   Gnecchi, Massimiliano ^a,b,c,e  

^a Laboratory of Clinical and Experimental Cardiology   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cardiac differentiation; Electrophysiology; MicroRNA; P19 cells; Stem cells

Indexed keywords

CONNEXIN 43; DIMETHYL SULFOXIDE; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 499; NIFEDIPINE; RYANODINE; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG; MIRN133 MICRORNA, MOUSE; MIRN499 MICRORNA, MOUSE;

ANIMAL CELL; ARTICLE; CALCIUM DEPLETION; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYOID BODY; EXCITATION CONTRACTION COUPLING; EXTRACELLULAR CALCIUM; GENE OVEREXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE CELL; CELL CULTURE; CELL LINE; DRUG EFFECTS; METABOLISM; ORGANOGENESIS; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; HUMANS; MICE; MICRORNAS; MYOCYTES, CARDIAC; ORGANOGENESIS;

EID: 84925664504     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1928     Document Type: Article

References (35)

1. McMurray JJ, Pfeffer MA., Heart failure. Lancet 2005; 365: 1877-1889.
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012; 380: 2095-2128.
3. Gnecchi M, Danieli P, Cervio E., Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol 2012; 57: 48-55.
4. Melo LG, Pachori AS, Gnecchi M, et al. Genetic therapies for cardiovascular diseases. Trends Mol Med 2005; 11: 240-250.
5. Aguirre A, Sancho-Martinez I, Izpisua Belmonte JC., Reprogramming toward heart regeneration: Stem cells and beyond. Cell Stem Cell 2013; 12: 275-284.
6. Sanganalmath SK, Bolli R., Cell therapy for heart failure: A comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 2013; 113: 810-834.
7. Gnecchi M, Zhang Z, Ni A, et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008; 103: 1204-1219.
8. Gnecchi M, He H, Liang OD, et al. Paracrine action accounts for marked protection of ischemic heart by akt-modified mesenchymal stem cells. Nat Med 2005; 11: 367-368.
9. Noiseux N, Gnecchi M, Lopez-Ilasaca M, et al. Mesenchymal stem cells overexpressing akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006; 14: 840-850.
10. Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004; 10: 494-501.
11. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-668.
12. Laflamme MA, Murry CE., Heart regeneration. Nature 2011; 473: 326-335.
13. McBurney MW., P19 embryonal carcinoma cells. Int J Dev Biol 1993; 37: 135-140.
14. van der Heyden MA, van Kempen MJ, Tsuji Y, et al. P19 embryonal carcinoma cells: A suitable model system for cardiac electrophysiological differentiation at the molecular and functional level. Cardiovasc Res 2003; 58: 410-422.
15. 2+ channels. In Vitro Cell Dev Biol Anim 1994; 30A: 425-434.
16. Seeger FH, Tonn T, Krzossok N, et al. Cell isolation procedures matter: A comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 2007; 28: 766-772.
17. Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38: 228-233.
18. Sluijter JP, van Mil A, van Vliet P, et al. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 2010; 30: 859-868.
19. Ivey KN, Muth A, Arnold J, et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2008; 2: 219-229.
20. Kwon C, Han Z, Olson EN, et al. MicroRNA1 influences cardiac differentiation in drosophila and regulates notch signaling. Proc Natl Acad Sci USA 2005; 102: 18986-18991.
21. Gallo P, Grimaldi S, Latronico MV, et al. A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells. Gene Ther 2008; 15: 161-170.
22. Altomare C, Barile L, Rocchetti M, et al. Altered functional differentiation of mesoangioblasts in a genetic myopathy. J Cell Mol Med 2013; 17: 419-428.
23. Bers DM., Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 2008; 70: 23-49.
24. Williams AR, Hatzistergos KE, Addicott B, et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 2013; 127: 213-223.
25. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705.
26. Chien KR., Stem cells: Lost in translation. Nature 2004; 428: 607-608.
27. Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428: 668-673.
28. Kawada H, Fujita J, Kinjo K, et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 2004; 104: 3581-3587.
29. Liechty KW, MacKenzie TC, Shaaban AF, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000; 6: 1282-1286.
30. Xu M, Wani M, Dai YS, et al. Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation 2004; 110: 2658-2665.
31. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103: 697-705.
32. Ohtani K, Dimmeler S., Control of cardiovascular differentiation by microRNAs. Basic Res Cardiol 2011; 106: 5-11.
33. Wilson KD, Hu S, Venkatasubrahmanyam S, et al. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: Role for miR-499. Circ Cardiovasc Genet 2010; 3: 426-435.
34. Zhang Q, Jiang J, Han P, et al. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res 2011; 21: 579-587.
35. 2+ signaling in the regulation of endothelial permeability. Vascul Pharmacol 2002; 39: 173-185.